Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

Clinical trial NCT02903537 · UNKNOWN

Trial details

NCT number: NCT02903537
Sponsor: Fundació Institut Germans Trias i Pujol
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Chronic Progressive

Start date: 2017-07-06
Primary completion: 2023-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.